Application of RPMI 2650 as a cell model to evaluate solid formulations for intranasal delivery of drugs

Title
Application of RPMI 2650 as a cell model to evaluate solid formulations for intranasal delivery of drugs
Authors
Keywords
RPMI 2650, Nasal epithelial cell model, Transepithelial electrical resistance, Mucus production, Air–liquid interface, Cytotoxicity, Drug permeation
Journal
INTERNATIONAL JOURNAL OF PHARMACEUTICS
Volume 515, Issue 1-2, Pages 1-10
Publisher
Elsevier BV
Online
2016-10-07
DOI
10.1016/j.ijpharm.2016.09.086

Ask authors/readers for more resources

Reprint

Contact the author

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now